Filing Details
- Accession Number:
- 0001104659-17-011292
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-23 17:25:08
- Reporting Period:
- 2017-02-21
- Filing Date:
- 2017-02-23
- Accepted Time:
- 2017-02-23 17:25:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1613859 | Pra Health Sciences Inc. | PRAH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1285101 | Colin Shannon | C/O Pra Health Sciences, Inc. 4130 Parklake Avenue, Suite 400 Raleigh NC 27612 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-21 | 2,747 | $2.94 | 2,747 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-21 | 2,747 | $61.50 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-02-23 | 97,253 | $2.94 | 97,253 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-23 | 97,253 | $61.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-02-21 | 2,747 | $0.00 | 2,747 | $2.94 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-02-23 | 97,253 | $0.00 | 97,253 | $2.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 121,890 | 2017-12-21 | No | 4 | M | Direct | |
| 24,637 | 2017-12-21 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The options vested on September 23, 2013.
Billionaire Hedge Funds
